Loading chat...
HI HB1132
Bill
Status
1/25/2017
Primary Sponsor
Joseph Souki
Click for details
AI Summary
-
Excludes apomorphine, butorphanol, dextrorphan, nalbuphine, nalmefene, naloxegol, naloxone, and naltrexone from Schedule I narcotic drug classifications to align with federal law.
-
Authorizes prescribing of Schedule III, IV, or V narcotic drugs approved by the FDA specifically for maintenance or detoxification treatment when practitioners comply with federal regulations under 21 CFR 1301.28.
-
Permits practitioners registered as narcotic treatment programs with the DEA to administer or dispense (but not prescribe) any schedule narcotic drug for maintenance or detoxification treatment.
-
Allows non-registered physicians to administer (not prescribe) narcotic drugs for emergency acute withdrawal relief for up to three days without renewal, limited to one day's medication per administration.
-
Redirects fines collected for violations of the Uniform Controlled Substances Act into the Controlled Substance Registration Revolving Fund instead of the state general fund, effective July 1, 2090.
Legislative Description
Relating To The Uniform Controlled Substances Act.
Uniform Controlled Substances Act
Last Action
Passed Second Reading as amended in HD 1 and referred to the committee(s) on JUD with none voting aye with reservations; none voting no (0) and Representative(s) Gates, Ing excused (2).
2/10/2017